← Leaderboards
Thomas L. Cherpes
Magee-Women'S Res Inst And Foundation
$9,554,133
Attributed
$9,554,133
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$9,554,133 · 7
By mechanism
R01$5,721,409 · 2
U19$2,435,453 · 2
R56$764,701 · 2
K23$632,570 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionWomanTissuesCellsGenital SystemVirusEpithelialHormonal ContraceptionContraceptive AgentsTransmission ProcessMediatingPredispositionVaginaT-LymphocyteProgestinsMucous MembraneHiv InfectionsDextransPeripheral Blood Mononuclear CellInjectablePermeabilityHigh RiskHigh Risk WomanClinical Research
Grant awards (25)
Developing a nonsteroidal and nonhormonal agent that reverses menopause-related loss of genital epithelial integrity and function$391,101
R56 · FY2023 · AG · contact PI
Estrogen reverses progestin-mediated loss of genital mucosal barrier function$750,708
R01 · FY2022 · HD · contact PI
Estrogen reverses progestin-mediated loss of genital mucosal barrier function$704,544
R01 · FY2021 · HD · contact PI
Estrogen reverses progestin-mediated loss of genital mucosal barrier function$69,387
R01 · FY2021 · HD · contact PI
Estrogen reverses progestin-mediated loss of genital mucosal barrier function$682,029
R01 · FY2020 · HD · contact PI
Estrogen reverses progestin-mediated loss of genital mucosal barrier function$410,473
R01 · FY2020 · HD · contact PI
Estrogen reverses progestin-mediated loss of genital mucosal barrier function$714,019
R01 · FY2019 · HD · contact PI
Estrogen reverses progestin-mediated loss of genital mucosal barrier function$717,135
R01 · FY2018 · HD · contact PI
Modulation of hormonal and systemic immunity by hormonal contraceptive use$386,320
R01 · FY2015 · HD · contact PI
Modulation of hormonal and systemic immunity by hormonal contraceptive use$392,723
R01 · FY2014 · HD · contact PI
Protective T cell responses to Chlamydial Infection$425,523
U19 · FY2013 · AI · contact PI
Protective T cell responses to Chlamydial Infection$278,648
U19 · FY2013 · AI · contact PI
Modulation of Hormonal and Systemic Immunity by Hormonal Contraceptive Use$210,098
R01 · FY2013 · HD · contact PI
Modulation of hormonal and systemic immunity by hormonal contraceptive use$186,547
R01 · FY2013 · HD · contact PI
Modulation of Hormonal and Systemic Immunity by Hormonal Contraceptive Use$497,426
R01 · FY2012 · HD · contact PI
Protective T cell responses to Chlamydial Infection$451,104
U19 · FY2012 · AI · contact PI
Protective T cell responses to Chlamydial Infection$484,657
U19 · FY2011 · AI · contact PI
Protective T cell responses to Chlamydial Infection$441,888
U19 · FY2010 · AI · contact PI
Tregs:sculpting a balance between protection and pathology during viral infection$373,600
R56 · FY2010 · AI · contact PI
Protective T cell responses to Chlamydial Infection$353,633
U19 · FY2009 · AI · contact PI
HSV-2 shedding: role of hormonal contraception and BV$126,630
K23 · FY2009 · AI · contact PI
HSV-2 shedding: role of hormonal contraception and BV$126,630
K23 · FY2008 · AI · contact PI
HSV-2 shedding: role of hormonal contraception and BV$126,630
K23 · FY2007 · AI · contact PI
HSV-2 shedding: role of hormonal contraception and BV$126,350
K23 · FY2006 · AI · contact PI
HSV-2 shedding: role of hormonal contraception and BV$126,330
K23 · FY2005 · AI